Showing results (1-10 of 72) with videos related to
Sort By:
Pageof 8
Blood Reviews|August 14, 2017
The who, how and why: Allogeneic transplant for acute myeloid leukemia in patients older than 60yearsSarah A Wall, Steven Devine, Sumithira VasuCurrent Hematology Reports|October 22, 2004
Cytokines and stem cell mobilization for autologous and allogeneic transplantationAmanda F Cashen, Daniel Link, Steven Devine, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2004
Human CD34+ hematopoietic progenitor cell-directed lentiviral-mediated gene therapy in a xenotransplantation model of lysosomal storage diseaseA Alex Hofling, Steven Devine, Carole Vogler, et al.Journal of Clinical Apheresis|October 20, 2004
Collection of a mobilized peripheral blood apheresis product from a patient with mucopolysaccharidosis type VII and subsequent CD34+ cell isolationA Alex Hofling, Mark S Sands, Douglas M Lublin, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 30, 2017
A retrospective review of fall risk factors in the bone marrow transplant inpatient serviceCory M Vela, Lisa M Grate, Ali McBride, et al.Blood|May 4, 2018
Recommendations for managing PD-1 blockade in the context of allogeneic HCT in Hodgkin lymphoma: taming a necessary evilCharles Herbaux, Reid Merryman, Steven Devine, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 24, 2018
Defining Competency to Empower Blood and Marrow Transplant and Cellular Immunotherapy Quality Management Professionals in HealthcareRamona Repaczki-Jones, Amanda K Hrnicek, Amy Heissenbuttel, et al.Transplantation and Cellular Therapy|April 10, 2021
A Qualitative Analysis of State Medicaid Coverage Benefits for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Patients with Sickle Cell Disease (SCD)Tatenda G Mupfudze, Jaime M Preussler, Jennifer A Sees, et al.Transplantation and Cellular Therapy|June 26, 2023
Estimating the Lifetime Medical Cost Burden of an Allogeneic Hematopoietic Cell Transplantation PatientRichard T Maziarz, Steven Devine, Louis P Garrison, et al.Hematology. American Society of Hematology. Education Program|November 25, 2003
Stem cell mobilizationMichele H Cottler-Fox, Tsvee Lapidot, Isabelle Petit, et al.Pageof 8